Sava Technologies announced today that it raised $19 million in a Series A financing round to support its wearable biosensor ...

What has changed in the last year as diabetes technology developers continue to innovate and advance their offerings?

Dexcom (Nadsaq:DXCM) today reported second-quarter financial results that came in ahead of the consensus forecast.

Sayer originally joined Dexcom’s board in November 2007, then became president in 2011. He held the role of COO, like Leach, until his promotion to CEO in 2015.

Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre ...

Beta Bionics (Nasdaq:BBNX) shares rose after hours today on raised 2025 guidance and second-quarter results that beat the ...

Stelo, the first FDA-cleared over-the-counter glucose biosensor, joins the G7 continuous glucose monitor (CGM) in offering ...

Additionally, Tandem intends to release a software update aimed at enhancing the early detection of speaker failure. The ...